Megan Hoffman
Nurse Practitioner · Harrisburg, ILNPI 1386931590
Payments from drug & device makers
Across 55 payments — averaging $17.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$135
- AstraZeneca$127
- Otsuka America Pharmaceutical, Inc.$90
- GSK$67
- Phathom Pharmaceuticals, Inc.$63
- Novartis$57
- plus $410 from 17 others
What the payments were for
- Food & beverage$949100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 8 | $135 |
| AstraZeneca | 9 | $127 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| GSK | 4 | $67 |
| Phathom Pharmaceuticals, Inc. | 5 | $63 |
| Novartis | 3 | $57 |
| Novo Nordisk | 3 | $50 |
| Lundbeck LLC | 2 | $43 |
| Dexcom, Inc. | 2 | $41 |
| AbbVie | 2 | $38 |
| Seqirus USA Inc | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| Braeburn Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Mylan Specialty L.p. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Verona Pharma, Inc. | 1 | $19 |
| Abbott | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Vertex | 1 | $15 |
| Pfizer | 1 | $14 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $9 |
How this compares
$949 in reported general payments places this provider in the 80th percentile of 4,869 nurse practitioner providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 41 | $559 |
| Doxycycline Hyclate | 46 | $388 |
| Lisinopril | 11 | $170 |
| Prednisone | 94 | $154 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $131 |
| Amoxicillin | 24 | $121 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $110 |
| Cephalexin | 18 | $109 |
| Azithromycin | 22 | $101 |
| Meclizine Hcl | 17 | $67 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Harrisburg
- Erika VuckoChicago$417K
- Deepa VallikatWest Dundee$332K
- Maria MalotoNaperville$135K
- Valerie LaroyOak Lawn$112K
- Jennifer LiebChampaign$109K
- Tanya MungerRockford$106K
- Kristy LukeChicago$77K
- Yvonna OldakerFlossmoor$74K
- Heather PiercePekin$72K
- Dara McKinleyEvanston$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.